Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts

BACKGROUND: Blood eosinophil counts have been documented as a good biomarker for patients with chronic obstructive pulmonary disease (COPD) using inhaled corticosteroid (ICS) therapy. However, the effectiveness and safety of prescribing high or medium dose of ICS for patients with different eosinoph...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Shih-Lung, Lin, Ching-Hsiung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036601/
https://www.ncbi.nlm.nih.gov/pubmed/27703344
http://dx.doi.org/10.2147/COPD.S115132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036601/
https://www.ncbi.nlm.nih.gov/pubmed/27703344
http://dx.doi.org/10.2147/COPD.S115132

Ejemplares similares